Wellnex Life Ltd stock analysis
Want to see AU:WNX full AI Analyst Report?
Wellnex Life Ltd (WNX) Share Price & Analysis
WNX Stock Chart & Stats
- Day’s Range
- AUD 0.06 - AUD 0.06
- 52-Week Range
- AUD 0.04 - AUD 0.19
- Previous Close
- AUD 0.06
- Volume
- N/A
- Average Volume (3M)
- 68.85K
- Market Cap
- AUD 4.38M
- Enterprise Value
- AUD 12.18M
- Total Cash (Recent Filing)
- AUD 862.00K
- Total Debt (Recent Filing)
- AUD 9.68M
- Price to Earnings (P/E)
- ―
- Beta
- 2.37
- Next Earnings
- Mar 04, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound
The sustained revenue recovery across two consecutive fiscal years indicates improving commercial scale and demand for Wellnex’s consumer health portfolio. Continued top-line expansion can strengthen distribution economics, support brand investment, and provide a foundation for future operating leverage.
Narrowing Losses
A reduction in losses suggests that the business is moving toward better earnings efficiency as revenue expands. Although profitability has not been achieved, continued improvement in the loss profile could preserve capital, reduce funding pressure, and support progress toward sustainable operating performance.
Rebuilding Equity Base
Rebuilding equity from the severely stressed FY2023 position improves the company’s capital base and provides greater resilience than its earlier balance-sheet condition. This stabilization may support ongoing operations and give management more flexibility as it works toward profitability and positive cash generation.
Bears Say
Weak Profitability
The sharp gross-margin decline shows that revenue growth is not yet translating into durable economic returns. Negative EBIT, EBITDA, and net margin indicate the core business remains unprofitable, limiting internally generated funding and making future performance sensitive to any continued margin weakness.
Persistent Cash Burn
Negative operating cash flow across all reported years indicates that the business still consumes cash in normal operations rather than funding itself. Even with improved burn versus FY2024, persistent cash outflows increase reliance on financing and could constrain investment until operations become sustainably cash-positive.
Renewed Leverage Pressure
The sharp increase in debt-to-equity reverses part of the earlier balance-sheet improvement and reduces financial flexibility while the company remains unprofitable. Declining total assets and deeply negative returns on equity further indicate that capital is not yet producing dependable shareholder returns.
Wellnex Life Ltd News
WNX FAQ
What was Wellnex Life Ltd’s price range in the past 12 months?
What is Wellnex Life Ltd’s market cap?
When is Wellnex Life Ltd’s upcoming earnings report date?
How were Wellnex Life Ltd’s earnings last quarter?
Is Wellnex Life Ltd overvalued?
Does Wellnex Life Ltd pay dividends?
What is Wellnex Life Ltd’s EPS estimate?
How many shares outstanding does Wellnex Life Ltd have?
What happened to Wellnex Life Ltd’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Wellnex Life Ltd?
What is the TipRanks Smart Score and how is it calculated?
Wellnex Life Ltd Stock Smart Score
Company Description
Wellnex Life Ltd
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
- Sector
- Consumerdefensive
- Industry
- Packaged Foods
- CEO
- Eric Jiang
- Employees
- 3
- Website
- wellnexlife.com.au
- Address
- Port Park - Building 2, Port Melbourne, VIC, 3207, AU
Wellnex Life Ltd (WNX) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 1 | 14 |
| Technical Analysis | 6 | 1 | 3 |
| Moving Averages | 1 | 0 | 11 |







